Skip Navigation LinksTestOrderMycoTBDrugSusceptibility1st

microbial diseases laboratory

Test Order Mycobacterium tuberculosis Complex: Drug Susceptibility Testing, First Line

Pre-Approval Required

None

Supplemental Information or Form

Form LAB 444 (03/12) (MDL-N-25), EXAMINATION FOR MYCOBACTERIA TUBERCULOSIS DRUG SUSCEPTIBILITY

Performed on Specimens From

California local public health laboratories

Acceptable Sample/Specimen Type for Testing

Pure culture

Minimum Volume Required

1 ml if broth

Storage & Preservation of Sample/Specimen Prior to Shipping

Incubated at 35-37°C (or refrigerated).

Transport

None

Sample/Specimen Labeling

Patient’s name, accession number, inoculation date or subculture date.

Shipping Instructions which Include Specimen Handling Requirements

Ship as infectious substance.

Test Methodology

By MGIT 960. Drugs routinely tested are isoniazid (INH) 0.1 μg/ml, rifampin 1 µg/ml, ethambutol 5 µg/ml, and pyrazinamide 100 µg/ml.  When there is resistance to any first-line drug, second-line drug susceptibility testing is performed.  In addition, when there is resistance to INH at 0.1 μg/ml, testing at  0.4 μg/ml is performed.

Turnaround Time

Average 2 weeks

Interferences & Limitations

Results unattainable because culture submitted is not pure.

Additional Information

None

MDL Points of Contact

Mycobacterial Diseases Section (drug susceptibilities) (510) 412-3929
Email: grace.lin@cdph.ca.gov

Page Last Updated :